Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Q3 2025 Contract Research Organization (CRO) Activity and Intel Report Featuring ICON, Astrazeneca, Akesobio, CSPPC Pharmaceutical, ImmunityBio, and Boryung

globenewswire.com
ICLR ICON plc is mentioned as a featured company in a report on CRO activity. The article does not provide specific sentiment or performance data for ICON. AZN AstraZeneca PLC is mentioned as a featured company in a report on CRO activity. The article does not provide specific sentiment or performance data for AstraZeneca. IMUX ImmunityBio, Inc. is mentioned as a featured company in a report on CRO activity. The article does not provide specific sentiment or performance data for ImmunityBio.

Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "Q3 2025 CRO Activity and Intel Report" report has been added to ResearchAndMarkets.com's offering.

This report offers an in-depth analysis of the contract research organization (CRO) industry, categorized by geography, therapeutic area, and phase of development for Q3 2025.

Report Scope

Reasons to Buy

Key Topics Covered:

Introduction

Clinical trials in oncology and CNS

North America

Europe

Rest of the world

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/nkeq25

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.